Results 61 to 70 of about 6,088 (209)
Despite advancements in the treatment of diffuse large B-cell lymphoma, including CAR T-cell therapy, TP53 mutations remain a significant negative prognostic factor in patients with relapsed/refractory diffuse large B-cell lymphoma.
Ziyi Cai +4 more
doaj +1 more source
Head and Neck Lymphoma in an Iranian Population [PDF]
Introduction: This study is aimed to assess the prevalence and characteristics of head and neck lymphoma in a defined group of an Iranian population. Materials and Methods: In this retrospective study, 126,450 biopsy reports from two referral Pathology
Nafiseh Shamloo +5 more
doaj +1 more source
Fibrin‐associated diffuse large B‐cell lymphoma [PDF]
n ...
Zanelli, Magda +4 more
openaire +3 more sources
Bioenergetic Materials for Tissue Regeneration: Modulating Metabolism to Promote Cellular Anabolism
Bioenergetic materials (BEMs) modulate cellular metabolism to promote tissue regeneration. Their principal mechanisms of action include metabolic substrate supplementation, metabolic enzyme modulation, organelle transfer, electrical current regulation, redox homeostasis modulation, and oxygen tension modulation.
Yuchen He +7 more
wiley +1 more source
Plasma Membrane Lipid Asymmetry Dynamically Regulates Passive Diffusion
Passive diffusion enables hydrophobic molecules to cross the plasma membrane and exert their biological functions. This study demonstrates that plasma membrane lipid asymmetry, dynamically regulated by lipid scrambling, determines membrane permeability to lipophilic molecules and thereby modulates their cellular activities.
Jieming Ping +4 more
wiley +1 more source
Hepatitis C virus has been found to be associated with B-cell non-Hodgkin lymphomas, mostly marginal zone lymphomas and diffuse large B-cell lymphoma. Deregulation of signaling pathways involved in normal marginal zone development (NOTCH pathway, NF-κB ...
Luca Arcaini +23 more
doaj +1 more source
The Genetic Landscape of Diffuse Large B-Cell Lymphoma [PDF]
Diffuse large B-cell lymphoma (DLBCL), the most common lymphoid malignancy in the western world, is an aggressive disease that remains incurable in approximately 30% of patients. Over the past decade, the rapid expansion of sequencing technologies allowing the genome-wide assessment of genomic and transcriptional changes has revolutionized our ...
PASQUALUCCI, Laura +1 more
openaire +2 more sources
A biomimetic nanoplatform (RPm@CC‐LY) remodels fibrotic stroma via sustained TGF‐β inhibition, triggers oxidative stress and apoptosis through Cu+‐mediated Fenton chemistry and Ca2+ overload, and reprograms macrophages and dendritic cells to boost CD8+ T cell infiltration.
Jianmei Li +6 more
wiley +1 more source
Guidelines for the management of diffuse large B‐cell lymphoma [PDF]
1Department of Haematology, Queen Elizabeth Hospital, Birmingham 2Department of Clinical Oncology, Christie Hospital, Manchester 3Department of Nuclear Medicine, Guys and St Thomas’ Hospitals, London 4Department of Haematology, West of Scotland Cancer Centre, Glasgow 5Department of Medical Oncology, Christie Hospital, Manchester 6Department of ...
Chaganti, Sridhar +9 more
openaire +3 more sources
ABSTRACT Chromosomal abnormalities have a major clinical impact on hematological malignancies, particularly with regard to treatment strategies. To preserve and consolidate fundamental knowledge in this rapidly evolving field, the Francophone Group of Hematological Cytogenetics (Groupe Francophone de Cytogénétique Hématologique, GFCH) conducted a ...
Florence Nguyen‐Khac +16 more
wiley +1 more source

